logo
This French Canadian Newspaper Cover About Trump Has Gone Super Viral

This French Canadian Newspaper Cover About Trump Has Gone Super Viral

Buzz Feed04-02-2025

Canadians on social media are showing a united front against Trump's proposed tariffs.
They're booing the American National Anthem at basketball games.
They're taking American goods off their shelves and telling people to "Buy Canadian Instead."
And they've even picked up some of their own "Fuck Trump" flags.
Le Journal de Montréal is known for being the largest circulation newspaper in Quebec, Canada. It's also widely recognized for its conservative editorial stance.
Well, their recent Trump cover has gone viral:
As this person said, "No translation needed," but for those wondering, it translates to: "Trump pushes his way closer to recession."
This cover is all over social media.
"Louvre bound," this person said.
"Quebec is Canada's super power. NEVER rile a Canadian Frenchman," another person said.
Le Journal de Montréal/ x.com
And this person wrote in French, "C'est vrais."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The Benefits And Drawbacks Of RFK Jr.'s New COVID Vaccine Recommendations
The Benefits And Drawbacks Of RFK Jr.'s New COVID Vaccine Recommendations

Forbes

time15 minutes ago

  • Forbes

The Benefits And Drawbacks Of RFK Jr.'s New COVID Vaccine Recommendations

SAVANNAH, GA - DECEMBER 15: A nurse shows off a vial of the Pfizer-BioNTech COVID-19 vaccine ... More outside of the Chatham County Health Department on December 15, 2020 in Savannah, Georgia. (Photo by) RFK Jr. and the HHS will no longer recommend annual COVID-19 vaccines for healthy pregnant women and young adults, according to a video announcement posted on X May 27 by Secretary of Health and Human Services Robert F. Kennedy Jr. A few days later, the CDC took a slightly different stance and stated that children between the ages of 6 months and 17 years may get the COVID-19 vaccine through shared decision-making between parents and healthcare providers. The CDC also updated the adult immunization schedule to say there is 'no guidance' on use for pregnancy. These decisions have sparked much debate among public health experts, policymakers and government officials. Here are the pros and cons of such a policy shift. As Kennedy cited in his video announcement, the U.S. seems to be aligning its vaccine policy with other countries such as the U.K. and Australia that have stopped recommending routine COVID-19 vaccines for young healthy adults. In addition, according to the new recommendations, the focus of vaccinations will largely be on high-risk populations, namely those who are 65 years of age and older as well as younger individuals with at least one medical condition that puts them at high risk for COVID-19. This could allow resources and attention to be redirected to the populations that need the vaccine most. The new recommendations also demand evidence in answering important questions the public deserves to know. For younger healthy American adults, getting approval for the vaccine will require placebo-controlled trials to show a benefit for that particular population. As an example, does a healthy 31-year-old male with no medical problems need to get a COVID-19 booster every single year, even after having received several COVID-19 boosters in the past? These are the types of questions that all Americans would like to and deserve to know with respect to COVID vaccinations. On the flip side, the new recommendations have many public health experts concerned. Pregnant healthy females could be barred from getting the COVID-19 vaccine, since the CDC has failed to provide guidance on the issue. Without a strong recommendation from the CDC, many pregnant patients could face real barriers from insurance companies to cover the vaccine, according to The New York Times. Pregnant women are at high risk for COVID infection and complications because pregnancy results in a weakened immune system. As Dr. Steven Fleischman, President of the American College of Obstetricians and Gynecologists states, 'The science has not changed. It is very clear that COVID infection during pregnancy can be catastrophic and lead to major disability.' The new recommendations could harm vulnerable populations. In addition to potential decreased vaccination rates and adverse outcomes for pregnant females, children could also suffer. When pregnant females get vaccinated against COVID-19 in the third trimester, they are able to pass along antibodies and protection to their infants, who have not developed mature immune systems. If pregnant females do not get vaccinated, infants will lack these antibodies and could then go on to develop severe complications from the virus should they get infected. Finally, the new recommendations could limit access to the vaccine to those that want it. Private insurance companies usually require FDA approval and CDC recommendations to cover the vaccine as part of health insurance. The current CDC recommendations simply state young children may get the vaccine with shared-decision making, not outright stating that they should get the vaccine. In addition, the CDC falls short in explicitly recommending the vaccine for pregnant females. This could prevent private insurance companies from fully covering the vaccine. Ultimately, this may mean some pregnant women and those that cannot afford the vaccine may not have access to it. The new recommendations for the COVID-19 vaccine for children and pregnant females was made without the customary use of independent advisors, and could have important implications for public health. While aligning with international practices, the move could significantly limit the amount of vaccines available for millions of Americans.

Discrimination cases unravel as Trump scraps core civil rights tenet
Discrimination cases unravel as Trump scraps core civil rights tenet

Washington Post

time16 minutes ago

  • Washington Post

Discrimination cases unravel as Trump scraps core civil rights tenet

For decades, the federal government has used data analysis to ferret out race and sex discrimination, winning court cases and reaching settlements in housing, education, policing and across American life. Now the Trump administration is working to unwind those same cases. In recent weeks, the Justice Department backed out of an agreement with an Atlanta bank accused of systematically discouraging Black and Latino home buyers from applying for loans. The Education Department terminated an agreement with a South Dakota school district where Native American students were disciplined at higher rates than their White peers. And federal prosecutors have dropped several racial discrimination reform agreements involving state and local police departments — including that of Minneapolis, where George Floyd was murdered by an officer in 2020.

Market Implications Of Tariff Litigation And AI Spending
Market Implications Of Tariff Litigation And AI Spending

Forbes

time17 minutes ago

  • Forbes

Market Implications Of Tariff Litigation And AI Spending

Despite what could be a lengthy legal battle, tariffs are unlikely to be removed completely. The ... More sectoral tariffs were not challenged and President Trump added additional steel tariffs on Friday. The tariff dispute does have some crucial implications for future trade deals and the tax bill. US economic data releases, which generally raised estimates of second-quarter economic growth, combined with strong earnings from Nvidia (NVDA), helped send stocks higher for the week. Additionally, improvement in consumer confidence helped raise optimism that the tariff overhang doesn't need to sink the economy. A portion of the tariffs implemented by the Trump administration was briefly overturned, though it was reinstated pending appeal. After the rally last week, the S&P 500 sits only 3.8% below its mid-February high. The Magnificent 7, consisting of Microsoft (MSFT), Meta Platforms (META), (AMZN), Apple (AAPL), NVIDIA (NVDA), Alphabet (GOOGL), and Tesla (TSLA), has fared worse, and the group is 5.5% below its mid-December summit despite outperforming last week. Market Performance The betting odds of a recession in 2025 have continued to decline. This improvement aligns with the supportive economic data released last week, which increased the estimates of US second-quarter GDP growth. Furthermore, the Conference Board's survey of consumer confidence rose after plummeting in the wake of President Trump's tariff announcements on Liberation Day. Betting Odds Of US Recession In 2025 Notably, stocks hit their April low when betting odds of recession were at their highest. As one should expect, the S&P 500 index has risen as the odds of a recession have declined. Stocks & Recession Odds Nvidia did not disappoint investors with better-than-expected quarterly earnings and robust guidance for second-quarter revenue growth of 50% year-over-year. Some worries that the spending on artificial intelligence (AI) infrastructure had weighed on the mega-cap technology companies, as represented by the Magnificent 7. In early April, the group was 30% below their mid-December peak. Most of this decline has reversed due to lower odds of recession. Additionally, the first-quarter earnings season provided evidence of both continued spending on AI infrastructure and, more importantly, proof that companies were successfully monetizing these AI investments into tangible earnings growth. Magnificent 7: Q1 Estimated Earnings Growth Last week, the Court of International Trade (CIT) struck down the majority of the tariffs implemented by the Trump administration. The sectoral tariffs, for example, those on autos and steel, were not impacted by this ruling. The tariffs removed include the 10% universal tariff, the reciprocal tariffs, and the specific tariffs targeting China, Canada, and Mexico. According to Strategas, this would remove about $220 billion in tariffs, leaving just $40 billion of those implemented since the start of the year. Within less than 24 hours after the ruling, the US Court of Appeals for the Federal Circuit granted a stay. Therefore, the tariffs will remain in place, and the US will not yet need to refund the tariff revenue collected to date. This litigation could be a lengthy process, but even if the tariffs are struck down at the end of the litigation, President Trump has the legal authority to reimpose tariffs via alternative methods. However, these methods come with some additional limitations. According to Strategas, Sections 338 and 122 of the Tariff Act of 1930 can be utilized quickly to reinstate many of the tariffs that are currently at risk. Section 338 allows for tariffs of up to 50% that take effect 30 days after announcement, with no time limit on their duration. Section 122 gives the president the authority to impose tariffs of up to 15% with immediate effect, but these tariffs can only remain in place for 150 days without congressional approval. Furthermore, Section 301 of the Trade Act of 1974 permits the imposition of tariffs following an investigation by the United States Trade Representative (USTR). It is doubtful that tariffs will go away unless President Trump decides that they are, but the utilization of other methods is more laborious, time-consuming, and comes with more limitations. Even though tariffs seem likely to remain a part of the investment landscape, regardless of the outcome of the litigation, there are some crucial implications of the additional uncertainty. On the margin, the possibility that the courts could remove the tariffs leaves the Trump administration with less leverage to negotiate trade deals with other countries. Countries may choose to stall and see what happens with the litigation. The G-7 meeting in June could provide some insight into whether any new deals are forthcoming. The tax bill passed by the US House of Representatives was debt-neutral if the revenue from the tariffs was included in the scoring. The risk to the tariff revenue may further complicate the Senate's deliberations in passing a version of the bill. Markets will remain on the tariffs, with markets watching for any changes in US policy and the progress of the legal challenge. Further, retaliation from or trade deals with other countries will be notable. The economic calendar has the critical monthly jobs report on Friday. Expectations are for nonfarm payroll job growth to slow to 125,000 from 177,000 in April. The unemployment rate is expected to remain steady at 4.2%. These forecasts are consistent with the weekly initial filings for unemployment benefits, which remain low and don't indicate a collapse in the labor market. Initial Jobless Claims Ongoing claims for unemployment benefits are rising, indicating that it is taking longer for those losing their jobs to find new employment. The labor market is showing signs of bending but not yet breaking. Continuing Claims Regardless of the outcome of the tariff litigation, tariffs are unlikely to be banished completely. To that point, President Trump imposed a 50% steel tariff late last Friday, and these sectoral tariffs are not part of the current legal challenge. Recent hard economic data, along with some soft data, such as consumer confidence, have raised optimism that US economic growth remains resilient. Furthermore, technology spending related to artificial intelligence continues, with the sector producing robust earnings growth. This week's jobs report will be another key indicator of the US economy's health.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store